MiR-34c and p53 were both significantly elevated in blood samples from AD patients, along with activation of the ROS/JNK pathway and a reduction in the synaptotagmin1 (Syt1) protein (Shi et al., 2020). This evidence concerns the gene TP53 and Alzheimer disease.